Mandatory Notification of Trade

09.12.2008 - Board member Lars H. Høie has today purchased 503.485 NUT shares at NOK 1,26 per share...

Read more about Mandatory Notification of Trade

Mandatory Notification of Trade

08.12.2008 - Development Director - Mike Clenshaw New has today purchased 500.000 NUT shares at NOK 1,25 per share from Lars Høie...

Read more about Mandatory Notification of Trade

Nutri5® Distribution Product Supply and Marketing Support Agreement

05.12.2008 - Nutri Pharma ASA has today signed a Distribution, Product Supply and Marketing Support Agreement with Nikken UK Ltd. This agreement will give Nikken the exclusive European distribution rights for Nutri5®...

Read more about Nutri5® Distribution Product Supply and Marketing Support Agreement

Third quarter 2008

20.11.2008 - Nutri Pharma today reports consolidated revenues of MNOK 23.9 and a consolidated EBIT of MNOK 0.2 for Q3 2008.....

Read more about Third quarter 2008

Meldepliktig handel

27.02.2008 - Mininaste AS, kontrollert av Dr. med. Egil Bodd, har i dag kjøpt 2 millioneraksjer i Nutri Pharma ASA av Lars H. Høie til kurs NOK 2,30 pr. aksje...

Read more about Meldepliktig handel

Nutri5 lanseres 8. februar på helsemessen Norges varemesse

10.01.2008 - Nutri5® - et nytt produkt for kvinner
- reduserer plager relatert til menopause og PMS
- forbedrer kvinners helse og livskvalitet

Read more about Nutri5 lanseres 8. februar på helsemessen Norges varemesse

Fourth Quarter 2007

27.02.2008 - (Oslo, 27 February 2008) Nutri Pharma (OSE: NUT)today reports revenues of NOK 17.4 million and an
EBITDA of NOK - 2.9 million for the fourth quarter
of 2007...

Read more about Fourth Quarter 2007

First order placed for `Nutrilett` in the Czech Republic

Nutri Pharma ASA has today received the first order from Delpharmea. This order is meant for a pre-launch of `Nutrilett`, marketed as Nutriline in the 350-400 largest pharmacies.

Read more about First order placed for `Nutrilett` in the Czech Republic

Notice of Annual General Meeting

The annual general meeting of Nutri Pharma ASA will be held Tuesday 29 April 2008, 10:00 a.m.

Read more about Notice of Annual General Meeting

First half year report 2008

MIG reports revenues of MNOK 23.4 which is 32 % higher than Q1 2008 and an increase of 34 % compared with Q2 2007.

Read more about First half year report 2008

Approved annual accounts 2007

On the 28 of March 2008, the Board of Directors
of Nutri Pharma ASA approved the annual accounts
for 2007.

Read more about Approved annual accounts 2007

Distribution and supply agreement for `Nutrilett`

Nutri Pharma ASA has today signed a distribution and supply agreement with Delpharmea Nutraceuticals AS in the Czech Republic.

Read more about Distribution and supply agreement for `Nutrilett`

First Quarter 2008

Nutri Pharma today reports consolidated revenues of MNOK 19.9 million (an increase of 47 % compared
with Q1 2007) and a consolidated loss of MNOK 3.2 million for the first quarter of 2008.

Read more about First Quarter 2008